期刊
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
卷 29, 期 5, 页码 840-843出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/13102818.2015.1043946
关键词
miR-155; breast cancer; oncogenic miRNA; target genes
资金
- Nature Science Foundation of Yunnan Province [2013FC006, KKSY201460043]
- Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education [2014016]
A major problem in the treatment of breast cancer at present is the lack of more sensitive and specific tumour biomarkers. MicroRNAs (miRNAs) were first discovered as important regulators of development in Caenorhabditis elegans, and their functions have been widely investigated. miR-155 is an oncogenic miRNA which has been explored mainly in leukaemia but is also known to play an important role in the progression of breast cancer. There is an accumulating body of evidence about additional roles of miR-155 in the development of breast cancer. In this mini-review, we provide an overview and update of miR-155 expression and its roles in breast cancer. We also attempt to summarize the current understanding of miR-155 regulation networks and speculate on the potential of miR-155 as a putative accessory parameter for diagnosis of breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据